Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MiniMed

This article was originally published in The Gray Sheet

Executive Summary

Firm's Model 508 insulin infusion pumps distributed between Oct. 4 and Nov. 18, 1999 could have "a rare and minor software error" that could lead to a patient receiving an incorrect dosage, the firm announced Nov. 19. Notification containing programming instructions has been sent to all users who purchased the pump during the relevant time period and new systems contain an upgraded version of the software. FDA has been notified but no adverse event reports have been filed, according to the company

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012617

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel